GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab, Bristol Myers Squibb's anti-PD-1 therapy, as ...
Like his dear old Gan-Gan in 1992, Harry has had something of his own annus horribilis in 2024 ... But when Harry was named as the winner of the Pat Tillman Award by US sports TV network Espy, awarded ...